Scientists develop ‘nanospear’ tech for cell and gene therapies
‘Splinter-like’ nanostructures have been developed by researchers in the US to deliver biomolecules straight into patient cells for immune-oncology and gene therapies.
Archives for March 21, 2018
News in Brief
MaSTherCell to make TCR candidates for Zelluna
Zelluna Immunotherapy has selected MaSTherCell as manufacturing partner for its T-cell receptor (TCR)-based immunotherapies.
WuXi Biologics adds 4,000L bioreactors at fully single-use site
The CMO says adding the single-use offering from ABEC will make the newly opened biomanufacturing site in China comparable to stainless steel for commercial mAb production.
BIOPHARMA AMBITION 2018
A top three biopharma by 2025? ‘Late to the game’ Sanofi plays catch-up
The traditionally small molecule firm was ‘late to the biologics game’, but Sanofi says a mixture of external partnerships and mergers are helping shift focus.